News

  • UK approves targeted MND treatment

    A genetic therapy called tofersen has been approved in the UK to treat SOD1-ALS, a rare inherited form of motor neurone disease. The drug targets amyotrophic lateral sclerosis (ALS) caused by mutations in the SOD1 gene – which produces an enzyme called superoxide dismutase 1 – leading to a toxic protein that damages nerve cells. [...]

  • Rowers take on 900-mile MND fundraising mission

    A four-person crew is attempting a 900-mile row from Land’s End to John O’Groats to raise £57m for motor neurone disease (MND) research over four years. The Row 4 MND team were set to leave Cornwall at around 08:30 BST and aim to reach Scotland via the Irish Sea in about 21 days. MND is [...]

  • National Rehab Centre invests in new bedside tech

    England’s new NHS National Rehabilitation Centre has signed a deal with tech firm Airwave Healthcare to supply intelligent bedside terminals to the new facility. The NRC will be run and staffed by Nottingham University Hospitals NHS Trust. It was originally scheduled to open by the end of 2024 before delays put the opening date back [...]

  • MPs launch disability equipment access inquiry

    A new parliamentary inquiry is seeking evidence on the barriers that prevent disabled people from getting the medical equipment they need. The All-Party Parliamentary Group (APPG) on Access to Disability Equipment launched its first call for evidence today. It is inviting responses from healthcare professionals, equipment suppliers, disabled individuals, their families and carers. Children’s disability [...]

  • Princess Anne opens garden for spinal patients

    Princess Anne has opened a new outdoor rehabilitation garden for patients with spinal cord injuries at Sheffield’s spinal injuries centre. The Princess Royal visited the Princess Royal Spinal Injuries Centre at the Northern General Hospital yesterday to formally open the accessible garden. Designed by Harris Bugg Studio and developed and run by spinal injury charity [...]

  • Roundup: Strategic partnership to develop a novel therapy for Alzheimer’s, and more

    NR Times explores the latest business and pharma developments in the world of neuro-rehabilitation. Strategic partnership to develop novel therapy for Alzheimer’s disease JCR Pharmaceuticals has entered into a joint collaboration with Acumen Pharmaceuticals to develop a novel therapeutic candidate for the treatment of Alzheimer’s disease (AD). The treatment is enabled by JCR’s [...]

  • Train to be named after rugby star and MND campaigner Rob Burrow

    Northern will name a train in honour of Rob Burrow, the Leeds Rhinos star who campaigned for motor neurone disease research before his death in June. The train operator is working with Burrow’s family and the MND Association to design artwork for the tribute, which aims to raise awareness of motor neurone disease – a [...]

  • Stroke Association apologises for social media posts

    The Stroke Association has deleted a series of social media posts and apologised after criticism from beneficiaries and other users over jokes about a viral video. On Friday, the charity joined other social media accounts in commenting on footage showing two people looking embarrassed after hugging at a Coldplay concert, with posts referencing rumours of [...]

  • Trainee solicitor takes on triathlon for Seashell Trust

    A trainee solicitor is taking part in a triathlon to raise vital funds for a charity which supports children and young people with disabilities. Alexander Lannigan will swim, cycle and run the Salford Triathlon this coming weekend, to raise money for the Seashell Trust. The charity works nationally to support children and young people with [...]

  • Switalskis expands personal injury team in London

    Law firm Switalskis has expanded its personal injury team in London with four senior hires and a new managing director of personal injury. Mark Hollinghurst, now managing director of personal injury, leads a team of more than 40, including specialists in brain and spinal injury. He will oversee growth from the London office. The new [...]